SGCG and viral infectious disease: Due to the more severe and prolonged symptomatic viral infections experienced in asthma,6, 7 supported by published data detailing increased virus loads7 and deficient anti‐viral immunity,8, 9 one could hypothesize that pDCs, a primary source of type I anti‐viral IFNs, would show reduced numbers in the airways in these patients.